Carlos Rodriguez-Lucas
Overview
Explore the profile of Carlos Rodriguez-Lucas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bolanos S, Acebes C, Martinez-Exposito O, Boga J, Fernandez J, Rodriguez-Lucas C
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061323
High-level delafloxacin-resistant (H-L DLX-R) isolates (minimum inhibitory concentration ≥1 mg/L) associated with mutations affecting position 84 of ParC have emerged. We aimed to elucidate the role of these mutations as...
2.
Fernandez-Caso B, Lumbreras-Iglesias P, Rodicio M, Fernandez J, Rodriguez-Lucas C
J Antimicrob Chemother
. 2023 Dec;
79(2):462-466.
PMID: 38153116
Objectives: The aims of this study were: (i) to assess the ability of the meropenem screening breakpoint as part of the screening rapid antimicrobial susceptibility testing (sRAST) of EUCAST for...
3.
Rodriguez-Lucas C, Ladero V
Antibiotics (Basel)
. 2023 May;
12(5).
PMID: 37237745
is a diverse genus of Gram-positive bacteria belonging to the lactic acid bacteria (LAB) group. It is found in many environments, including the human gut and fermented foods. This microbial...
4.
Pradal I, Casado A, Rio B, Rodriguez-Lucas C, Fernandez M, Alvarez M, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680219
The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) belongs. Phage therapy has emerged...
5.
Rodriguez-Lucas C, Fernandez J, Vazquez X, de Toro M, Ladero V, Fuster C, et al.
Microb Drug Resist
. 2022 Jun;
28(7):773-779.
PMID: 35727074
Dispersion of transferable oxazolidinone resistance genes among enterococci poses a serious problem to human health. Prompt detection of bacteria carrying these genes is crucial to avoid their spread to multidrug-resistant...
6.
Rodriguez-Lucas C, Fernandez J, Raya C, Bahamonde A, Quiroga A, Munoz R, et al.
Microb Drug Resist
. 2021 Oct;
28(2):217-221.
PMID: 34705570
Vancomycin-resistant (VREfm) is one of the most important nosocomial pathogens with limited therapeutic alternatives. In this study, we followed the trends of VREfm and causing bloodstream infections (BSIs) in a...
7.
Rodriguez-Lucas C, Rodicio M, Vazquez X, Escudero D, Quindos B, Alaguero M, et al.
Eur J Clin Microbiol Infect Dis
. 2020 Aug;
40(2):385-389.
PMID: 32808109
The aim of the study was to evaluate for a long time the effectiveness of an intervention designed to reduce carbapenem-resistant Acinetobacter baumannii (CRAB) and its impact on colistin usage...
8.
Pintado V, Pazos R, Jimenez-Mejias M, Rodriguez-Guardado A, Diaz-Pollan B, Cabellos C, et al.
Infect Dis (Lond)
. 2020 Jul;
52(11):808-815.
PMID: 32648796
Background: Linezolid has good penetration to the meninges and could be an alternative for treatment of meningitis. We assessed the efficacy and safety of linezolid therapy for this infection. Methods:...
9.
Rodriguez-Lucas C, Fernandez J, Martinez-Sela M, Alvarez-Vega M, Moran N, Garcia A, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2019 May;
38(2):54-58.
PMID: 31126690
Background: Pseudomonas aeruginosa neurosurgical meningitis is a rare entity, usually related with intraventricular catheters and associated with high mortality rates. We describe the clinical characteristics, treatment and outcomes of a...
10.
Li S, Han Z, He J, Gao S, Liu D, Liu L, et al.
J Thorac Dis
. 2019 Jan;
10(11):6356-6374.
PMID: 30622808
No abstract available.